Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2

Journal of Clinical Microbiology

Volumn 36, Issue 6, 1998, Pages 1534-1538

  Morandi, Pierre Alain ^a   Schockmel, Gérard A ^a   Yerly, Sabine ^a   Burgisser, Philippe ^b   Erb, Peter ^c   Matter, Lukas ^d   Sitavanc, Radan ^e   Perrin, Luc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Bio Analytique Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RNA ANALYSIS; VIRUS DETECTION;

HIV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0031957793     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.6.1534-1538.1998     Document Type: Article

References (28)

1. Alaeus, A., K. Lidman, A. Sönnerborg, and J. Albert. 1997. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865.
2. Ayres, L., F. Avillez, A. Garcia-Benito, F. Deinhardt, L. Gurtler, F. Denis, G. Leonard, S. Ranger, P. Grob, H. Joller-Jemelka, G. Hess, S. Seidl, H. Flacke, F. Simon, F. Brun-Vézinet, D. Sondag, A. André, H. Hampl, R. Schoen, S. Stramer, and H. Troonen. 1990. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. AIDS 4:131-138.
3. Baumberger, C., S. Kinloch-de-Loes, S. Yerly, B. Hirschel, and L. Perrin. 1993. High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS 7(Suppl. 2):S59-S64.
4. Busch, M. P., L. L. Lee, G. A. Satten, D. R. Henrard, H. Farzadegan, K. E. Nelson, S. Read, R. Y. Dodd, and L. R. Petersen. 1995. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35:91-97.
5. Busch, M. P., and A. M. Couroucé. 1997. Relative sensitivity of United States and European assays for screening blood donors for antibodies to human immunodeficiency virus. Transfusion 37:352-353.
6. Couroucé, A. M., F. Barin, M. Maniez, C. Janot, L. Noel, and M. H. Elghouzzi. 1992. Effectiveness of assays for antibodies to HIV and p24 antigen to detect very recent HIV infections in blood donors. Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 6:1548-1550. (Letter.)
7. Coutlee, F., G. Delage, F. Lamothe, S. Cassol, and F. Decary. 1992. Transmission of HIV-1 from seronegative but PCR-positive blood donors. Lancet 340:59. (Letter.)
8. De Saussure, P., S. Yerly, E. Tullen, and L. H. Perrin. 1993. Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor. Transfusion 33:164-167.
9. Galetto-Lacour, A., S. Kinloch-de-Loës, B. Hirschel, and L. Perrin. 1995. Primo-infection VIH: un diagnostic souvent évoqué mais posé tardivement. Schweiz. Med. Wochenschr. 125:341-346.
10. Gallarda, J. L., D. R. Henrard, D. Liu, S. Harrington, S. L. Stramer, J. E. Valinsky, and P. Wu. 1992. Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J. Clin. Microbiol. 30: 2379-2384.
11. Holodniy, M., S. Kim, D. Katzenstein, M. Konrad, E. Groves, and T. C. Merigan. 1991. Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29:676-679.
12. Horsburgh, C. R., C. Y. Ou, J. Jason, S. D. Holmberg, I. M. Longini, C. Schable, K. H. Mayer, A. R. Lifson, G. Schochetman, and J. W. Ward. 1989. Duration of human immunodeficiency virus infection before detection of antibody. Lancet ii:637-640.
13. Krivine, A., A. Yakudima, M. Le May, V. Pena-Cruz, A. S. Huang, and K. McIntosh. 1990. A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J. Pediatr. 116:372-376.
14. Lederberger, B., J. von Overbeck, M. Egger, and R. Lüthy. 1994. The Swiss HIV cohort study: rationale, organization and selected baseline characteristics. Soz. Präventivmed. 39:387-394.
15. McMahon, E. J., C. Fang, L. Layug, and S. G. Sandler. 1995. Pooling blood donor samples to reduce the cost of HIV-1 antibody testing. Vox Sang. 68: 215-219.
16. Michael, N., M. Robb, D. Birx, J. R. Mascola, J. Wang, K. Dreyer, K. McDonough, C. Christopherson, S. D. Lu, S. Kwok, and S. Herman. 1997. Performance of the Amplicor HIV-1 Monitor test and a modified HIV-1 Monitor test on HIV-1 subtypes A to F, abstr. 279. In Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections.
17. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
18. Mulder, J., R. Resnick, B. Saget, S. Scheibel, S. Herman, H. Payne, R. Harrigan, and S. Kwok. 1997. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J. Clin. Microbiol. 35:1278-1280.
19. Petersen, L. R., G. A. Satten, R. Dodd, M. Busch, S. Kleinman, A. Grindon, and B. Lenes. 1994. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion 34:283-289.
20. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by comparative PCR. Science 259: 1749-1754.
21. Revets, H., D. Marissens, S. de Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
22. Schacker, T., A. C. Collier, J. Hughes, T. Shea, and L. Corey. 1996. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125: 257-264.
23. Schockmel, G. A., S. Yerly, and L. Perrin. 1997. Detection of low HIV-1 RNA levels in plasma. J. Acquired Immune. Defic. Syndr. Hum. Retroviral. 14:179-183.
24. Schreiber, G. B., M. P. Busch, S. H. Kleinman, and J. J. Korelitz. 1996. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N. Engl. J. Med. 334:1685-1690.
25. Sherlock, C. H., S. A. Strathdee, T. Le, D. Sutherland, M. V. O'Shaughnessy, and M. T. Schechter. 1995. Use of pooling and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in British Columbia, Canada. AIDS 9:945-950.
26. Simonds, R. J., S. D. Holmberg, R. L. Hurwitz, T. R. Coleman, S. Bottenfield, L. J. Conley, S. H. Kohlenberg, K. G. Castro, B. A. Dahan, C. A. Schable, M. A. Rayfield, and M. F. Rogers. 1992. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 326:726-732.
27. Ward, J. W., S. D. Holmberg, J. R. Allen, D. L. Cohen, S. E. Critchley, S. H. Kleinman, B. A. Lenes, O. Ravenholt, J. R. Davis, M. G. Quinn, and H. W. Jaffe. 1988. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N. Engl. J. Med. 318: 473-478.
28. Zaaijer, H. L., P. van Exel-Oehlers, T. Kraaijeveld, E. Altena, and P. N. Lelie. 1992. Early detection of antibodies to HIV-1 by third-generation assays. Lancet 340:770-772.